Seer, Inc. (California) (SEER)
2.03
-0.01
(-0.49%)
USD |
NASDAQ |
Oct 16, 16:00
2.03
0.00 (0.00%)
After-Hours: 20:00
Seer SG&A Expense (TTM) : 40.06M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 40.06M |
| March 31, 2026 | 40.57M |
| December 31, 2025 | 42.58M |
| September 30, 2025 | 45.65M |
| June 30, 2025 | 48.29M |
| March 31, 2025 | 53.72M |
| December 31, 2024 | 56.57M |
| September 30, 2024 | 56.74M |
| June 30, 2024 | 58.22M |
| March 31, 2024 | 58.20M |
| December 31, 2023 | 58.95M |
| September 30, 2023 | 60.49M |
| June 30, 2023 | 61.17M |
| March 31, 2023 | 59.27M |
| Date | Value |
|---|---|
| December 31, 2022 | 58.53M |
| September 30, 2022 | 57.01M |
| June 30, 2022 | 53.42M |
| March 31, 2022 | 49.73M |
| December 31, 2021 | 45.76M |
| September 30, 2021 | 40.63M |
| June 30, 2021 | 32.50M |
| March 31, 2021 | 23.92M |
| December 31, 2020 | 13.58M |
| September 30, 2020 | 7.271M |
| June 30, 2020 | 3.545M |
| March 31, 2020 | 1.643M |
| December 31, 2019 | 1.643M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Champions Oncology, Inc. | 21.81M |
| Medpace Holdings, Inc. | 189.02M |
| Avantor, Inc. | 1.599B |
| Personalis, Inc. | 67.03M |
| Adaptive Biotechnologies Corp. | 180.38M |